Any morning now we wake up, the results will be out guys.
Any morning now we wake up, the results will be out guys.
My twin boys were born 17 weeks premature and I can confirm that they had no specific hearing protection. Neonatal is indeed very loud 24/7. Unfortunately the stress of two extreme prematures is one of the reasons I am currently here as the tinnitus was brought on from the anxiety and insomnia.This is so interesting - I was born 11 weeks premature and spent the first 10 weeks in a neonatal unit but I'm not sure if I would have been fitted with hearing protection. I read that neonatal units actually tend to be quite noisy too. I wonder if that could have contributed to cumulative noise damage.
That is due to Retinopathy of Prematurity, which is extremely common in very premature babies. It has a lot to do with Oxygen saturation from breathing support/ventilation during the early stages due to lack of lung development in prematures.I know someone who was born very premature and lost her sight at the age of nine, and I wonder if that was likewise due to an unprotected vulnerability in the neonatal period. On that same note, I wonder if Frequency Therapeutics' regenerative technologies have any applicability down the road for retinal restoration.
Wake up from what... sleep? I think you're making an assumption here.Any morning now we wake up, the results will be out guys.
FX-322 showed improvements on the audiogram at the 8 kHz range. If we see continued improvements on the audiogram at and above 8 kHz from the Phase 2a trial, it's reasonable to think that FX-322 will eventually help at 4 kHz.How likely is it that my tinnitus is caused by a -5 dB drop in the 4 kHz range? My ENT says that it's the likely cause of my tinnitus although I haven't done a 16 kHz audiogram yet.
In the hypothetical scenario that my tinnitus is caused by the -5 dB dip in the 4 kHz range, then will FX-322 not work for me?
It's definitely possible to be the cause of the tinnitus. It largely depends on how sensitive your brain is to changes.How likely is it that my tinnitus is caused by a -5 dB drop in the 4 kHz range? My ENT says that it's the likely cause of my tinnitus although I haven't done a 16 kHz audiogram yet.
In the hypothetical scenario that my tinnitus is caused by the -5 dB dip in the 4 kHz range, then will FX-322 not work for me?
So what kind of information can we actually expect from this 90 day data analysis?
They seem to only update the presentation when it is warranted, because it has to be filed with the SEC. I suspect that the morning they release the PR on the 90-day readout, they'll also file a spanking-new deck with all the 90-day data for people like us to scan through and over-analyze, and debate here on Tinnitus Talk what it all means until June.Their Events and Presentations sections still shows their February 2021 presentation:
https://investors.frequencytx.com/events-and-presentations
I wonder if this signals that the results will happen sometime soon rather than towards the end of the month. If they were planning on having the results at the end of the month, I would assume they would release an updated March 2021 presentation. However, if the results were to happen soon, I would assume they'd want their March 2021 presentation to contain info about those results.
I admit that I may be reaching a little here, but it's interesting that they didn't update the presentation. It would be a little odd if they released a March 2021 presentation towards the end of the month.
You mean... like... curing baldness?Some have mentioned that Frequency Therapeutics has already issued patents for regenerating hair follicles
Yes.
They made the announcement in their October 29, 2020 press release.Does anyone remember when they announced they would release 90-day data? How much data did they have at that point?
I keep coming back to the fact that they aren't required to release interim data, so I can't imagine they'd want to unless they very strongly suspected it would be good...
I believe it was in the Oct 29, 2020 Press Release when they first announced the 90-day release being "Late Q1 / 2021"Does anyone remember when they announced they would release 90-day data? How much data did they have at that point?
I keep coming back to the fact that they aren't required to release interim data, so I can't imagine they'd want to unless they very strongly suspected it would be good...
I think it'll be sooner, they have a big conference coming up on the March 17th, they're even sponsoring it; It makes sense for them to release the data before that date so they can boast about it.Let's all be mindful of what is probably going on at Frequency Therapeutics:
They still have not done their Year-End/Q4 2020 business update (last year it was on March 26th). These take a lot of work for a company to compile, review for compliance, and submit.
It's possible that they include the Interim Analysis as part of the Year-End announcement. It's also likely that they're working up other marketing materials to reinforce the findings in the Phase 2A 90-day. The firm has been quick to communicate the benefits of FX-322, so they may want to have that marketing pipeline in place prior to the announcement. They're already producing pretty high quality videos from the Phase 1/2 data, these are typically 2-4 week long projects to do motion-graphic projects like they have shared recently.
Hopefully they don't wait until March 26th again, but I am optimistic that it will be worth the wait.
All this means to me is that it's a good idea to buy, buy, buy as it'll inevitably shoot to the moon after the successful results!I know the stock price means nothing, but I'd sort of feel better if it stopped dropping.
Just a point on this for everyone to keep in mind. As you will notice, it says "group level" data. This is because they are only unblinding themselves at the group level. Carl LeBel said in the presentation that they wouldn't unblind themselves at the individual level until the full readout. Hopefully this pre-empts any speculation as to why they may not divulge any specific data beyond the group level.
Yeah, I had thought about that... how embarrassing would be it to sponsor the Hearing Healthcare Conference, pay for 55 students to attend, headline the event with a "Hair Cell Regeneration Advancements" presentation hosted by one of the founders, and the trial ends up being a goose egg... not likely, I suppose.I think it'll be sooner, they have a big conference coming up on the March 17th, they're even sponsoring it; It makes sense for them to release the data before that date so they can boast about it.
This also means that they can provide a group-level baseline. So, let's all just look for the 4x group page and see how good it gets...Just a point on this for everyone to keep in mind. As you will notice, it says "group level" data. This is because they are only unblinding themselves at the group level. Carl LeBel said in the presentation that they wouldn't unblind themselves at the individual level until the full readout. Hopefully this pre-empts any speculation as to why they may not divulge any specific data beyond the group level.
Are we sure they are providing like a formal report of the interim results? Could it be just a press release with the tests and p values?This also means that they can provide a group-level baseline. So, let's all just look for the 4x group page and see how good it gets...
Carl LeBel mentioned in the January webinar that we should expect to see group level averages that show both % of improvement and a numeric improvement from baseline.Are we sure they are providing like a formal report of the interim results? Could it be just a press release with the tests and p values?
I asked 2 audiologists and one PA about the scores because mine are right on the line. They all said there is a standard of deviation for testing. So even though my scores are slightly different they allow for differences in testing within 5-10 dB.I asked my audiologist about my extended audiograms where I clearly have some hearing loss and asked her how bad it was was. She said that it was hard to answer because there really aren't accepted medical standards for what hearing sensitivity at those ranges are supposed to be.
Is this right or is the 20 dB of loss still considered the standard?
Can you imagine improving your score from 28 to 10? At that point it becomes the "meh" tinnitus.Carl LeBel mentioned in the January webinar that we should expect to see group level averages that show both % of improvement and a numeric improvement from baseline.
They can't show p-val without individual scores known.
I would expect something like:
The 1x group had a baseline average of 26 words, and at 90 days averaged 46 words.
and
The 4x group had a baseline average of -50 dB at 8 kHz and averaged -10 dB at 90 days.
and
The 2x group had a tinnitus baseline average score of 28 and at 90 days improved to 10.
This honestly makes me suspect the 17th is the date they will announce data.Yeah, I had thought about that... how embarrassing would be it to sponsor the Hearing Healthcare Conference, pay for 55 students to attend, headline the event with a "Hair Cell Regeneration Advancements" presentation hosted by one of the founders, and the trial ends up being a goose egg... not likely, I suppose.
That would give me my life back!Can you imagine improving your score from 28 to 10? At that point it becomes the "meh" tinnitus.
That would be a clinically meaningful improvement in terms of TFI. A 10 or less describes people that only hear it in quiet rooms and probably aren't bothered by it daily, maybe even weekly.Can you imagine improving your score from 28 to 10? At that point it becomes the "meh" tinnitus.